NephroGenex (NRX) Terminates CEO Pierre Legault, Chief Scientific Officer Jaikrishna Patel
Tweet Send to a Friend
NephroGenex (NASDAQ: NRX) disclosed that effective as of April 13, 2016, the Company terminated Pierre Legault’s employment as the Chief ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
